Download Presentation Clinical Training Videos for Youth E-Cigarette Use These brief training videos showcase a clinical interaction between pediatricians and adolescents about 4 key elements of e-cigarette screening and counseling (English and Spanish captions available)
Listen this article The tobacco company announced the purchase of a large part of the leading cannabinoid company in Canada and their plan to expand IGNORE INTO an emerging market The tobacco company announced the purchase of a large part of the leading cannabinoid company in Canada and their plan to expand IGNORE INTO an emerging market Altria Group, the company that owns the tobacco company Phillip Morris and a large part of the SAB Miller brewery, announced last Friday that they agreed to purchase 45% of the company Cronos Group, the leader in cannabinoid production in Canada
GPs are normally the first point of contact for patients
The regulatory challenge of electronic cigarettes
Drugs and Biologicals With Average Annual Total Cost Under Part D Below the Applicable Threshold Under section 1860D-14B(g)(1)(B) of the Act, a drug or biological is excluded from the definition of a Part D rebatable drug if the average annual total cost under Part D for such period per individual who uses such a drug or biological product is less than $100 per year, as determined by the Secretary using the most recent data available, or, if data are not available, as estimated by the Secretary